Moreover, GACAT3 is included in an established ovarian cancer eight-lncRNA signature, which predicts chemotherapy response and platinum-resistance (Zhou et al., 2016; Klymenko et al., 2017). The gene discussed is GACAT3; the disease is ovarian carcinoma.